Clinical Trial Update: ATRA, Celecoxib, and Itraconazole as Maintenance [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated maintenance therapy with a triplet of ATRA (all-trans retinoic acid), celecoxib, and itraconazole in relapsed multiple myeloma. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ATRA (all-trans retinoic acid) (all-trans retinoic acid)
• Celecoxib (Celecoxib)
• Itraconazole (Itraconazole)

Snippet

Sponsor: University of Iowa | Conditions: Relapsed Multiple Myeloma | Phase 1 | Status: COMPLETED